Mitral Valve Replacement with Thymectomy in a Patient with Ocular Myasthenia Gravis: Case Report
Keywords:ocular myasthenia gravis, thymectomy, mitral valve replacement
Patients diagnosed with ocular myasthenia gravis (MG) and mitral valve disease represent a significant perioperative management problem, especially for the anaesthesiologist, due to complex inter-actions between the disease, drugs to treat the disease, and anaesthetic agents, such as neuromuscu-lar blocking agents (NMBAs).
This paper describes the successful management of a 31-year-old female with mitral valve stenosis and ocular MG who was diagnosed with MG 4 years prior to the indication for cardiac surgery. Preoperatively, the patient was under treatment with Pyridostigmine and Prednisone. Mitral valve replacement and full thymectomy were performed, under general anaesthesia, using Fentanyl, Sevoflurane and low doses of non-depolarising NMBAs.
The postoperative course was uneventful, the patient was extubated at 6 hours postoperatively, in-tensive care unit stay was 48 hours, and the patient was discharged after 6 days without any compli-cations. After 3 months, at the follow-up examination, the patient’s ocular symptoms (eyelid ptosis) disappeared.
Aps C, O’Sullivan G. 1987. Myasthenia gravis and cardiac surgery. Br J Anaesth. Feb;59(2):265-8.
Wang Q, Xu Z, Lin B, Lu F, Cui Y. 2011. Simultaneous Operation for Multiple Valvular Disease and Myasthenia in a Woman. Heart Lung Circ. Feb; 20(2):130-1.
Aydin Y, Ulas AB, Mutlu V, Colak A, Eroglu A. 2017. Thymectomy in Myasthenia Gravis. Eurasian J Med. Mar 31;49(1):48-52.
Blichfeldt-Lauridsen L, Hansen BD. 2012. Anesthesia and myasthenia gravis. Acta Anaesthesiol Scand. Jan;56(1):17-22.
Conti-Fine BM, Milani M, Kaminski HJ. 2006. Myasthenia gravis: past, present, and future. J Clin Invest. Nov 1;116(11):2843-54.
Dillon F. 2014. Anesthesia Issues in the Perioperative Management of Myasthenia Gravis. Semin Neurol. Jul 1;24(01):83–94.
Drachman D. 1994. Myasthenia Gravis. N Engl J Med. 330(25):1797-810.
Ishimura H, Sata T, Matsumoto T, Takizuka A, Shigematsu A. Anesthetic Management of a Patient with Myasthenia Gravis During Hypothermic Cardiopulmonary Bypass. 1998. J Clin Anesth. May;10(3):228-31.
Kalb B, Matell G, Pirskanen R, Lambe M. 2002. Epidemiology of Myasthenia gravis: A Population-Based Study in Stockholm, Sweden. Neuroepidemiology. 21(5):221-5.
Li K-K, Qian K, Feng Y-G, Guo W, Tan Q-Y, Deng B. 2017. Predictive factors of prolonged me-chanical ventilation, overall survival, and quality of life in patients with post-thymectomy myas-thenic crisis. World J Surg Oncol [Internet]. 2017 Dec [cited 2018 Aug 28];15(1).
Narin C, Sarkilar G, Tanyeli O, Ege E, Yeniterzi M. 2009. Successful mitral valve surgery in a patient with myasthenia gravis. J Card Surg. 24(2):210-2.
Shivamurthy P, Parker MW. 2014.Cardiac manifestations of myasthenia gravis: A systematic re-view. IJC Metab Endocr. Nov;5:3–6.
Vaphiades MS, Bhatti MT, Lesser RL. 2012. Ocular myasthenia gravis: Curr Opin Ophthalmol. Nov;23(6):537-42.
Vincent A, Palace J, Hilton-Jones D. 2001. Myasthenia gravis. Lancet. 357:2122-8.
Yuan HK, Huang B-S, Kung S-Y, Kao K-P. 2007. The effectiveness of thymectomy on seronega-tive generalized myasthenia gravis: comparing with seropositive cases. Acta Neurol Scand. Mar;115(3):181–4.